n,n-dimethylarginine has been researched along with Acute Hypercapnic Respiratory Failure in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bassi, F; Böger, R; Cescutti, D; Cifù, A; Curcio, F; Fabris, M; Fapranzi, S; Hannemann, J; Ripoli, A; Sbrana, F; Sozio, E; Sponza, M; Tascini, C; Vetrugno, L | 1 |
1 other study(ies) available for n,n-dimethylarginine and Acute Hypercapnic Respiratory Failure
Article | Year |
---|---|
The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome.
Topics: Arginine; Biomarkers; COVID-19; Humans; Respiratory Insufficiency; RNA, Viral; SARS-CoV-2 | 2023 |